Two Sigma Advisers
BLFS icon

Two Sigma Advisers’s BioLife Solutions BLFS Stock Holding History

Two Sigma Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,800
Closed -$260K – 2556
2022
Q2 		$260K Buy
18,800
+5,000
+36% +$73.4K ﹤0.01% 2167
2022
Q1 		$314K Buy
+13,800
New +$363K ﹤0.01% 2202
2021
Q2 		– Sell
-22,900
Closed -$824K – 2457
2021
Q1 		$824K Buy
+22,900
New +$905K ﹤0.01% 1754
2019
Q1 		– Sell
-25,900
Closed -$312K – 2301
2018
Q4 		$312K Buy
25,900
+9,100
+54% +$109K ﹤0.01% 1964
2018
Q3 		$294K Buy
16,800
+4,600
+38% +$91K ﹤0.01% 1959
2018
Q2 		$139K Buy
+12,200
New +$111K ﹤0.01% 2250

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers's BLFS Position: Q3 2022 in Review

Two Sigma Advisers sold out of BioLife Solutions (BLFS) in Q3 2022, closing a stake of 18,800 shares — an estimated $260K sold.

Two Sigma Advisers first reported a position in BLFS in Q2 2018 and held it in 6 quarters. The position peaked at $824K in Q1 2021. 174 funds tracked by Wall St. Rank hold BLFS as of Q3 2022.

  • Two Sigma Advisers reported no remaining BioLife Solutions position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 18,800 BioLife Solutions shares in Q3 2022, an estimated $260K.
  • Two Sigma Advisers first reported a position in BioLife Solutions in Q2 2018 and held it in 6 quarters.
  • Two Sigma Advisers's BioLife Solutions position peaked at $824K in Q1 2021.
  • 174 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.